In an effort to localize the effects of anesthesia, researchers have turned to magnetic nanoparticles to target the delivery of ropivacaine in a proof-of-concept animal study.
At MIT, researchers have developed nanoparticles that can carry as many as three cancer drugs at a time in a precise ratio.
As drug delivery becomes more and more dependent on nanotechnology for treatments such as chemotherapy, it's important that scientists in the field understand the implications of the tiny vehicles and what factors might play a part, for good or bad, in their delivery potential.
Engineers have developed a method to measure the density of nanomaterials as they come into contact with cells and tissue. Beyond the safety aspect of being able to determine the amount of exposure a patient has had to nanoparticles, the method could also be used to help develop new drug delivery systems that make use of the tiny materials.
Here at FierceDrugDelivery, we write often about innovations in nanotechnology as it becomes more and more important in the delivery field. These advances are mostly in the very early stages, but they're still promising as the delivery field moves even further into the nanoscale.
San Diego drug delivery company Sonrgy snagged exclusive rights to an ultrasound-based nanotech delivery platform conceived at the University of California, San Diego.
A microparticle therapy developed by researchers at Northwestern Medicine and the University of Sydney in Australia may be able to restore heart tissue damaged by inflammation following a heart attack.
Analysts predict the global market for nanotechnology in medicine, which amounted to almost $79 billion in 2012, will surpass $177 billion by 2019.
To get microscopic drug carriers swimming toward a target, German researchers took a cue from some of the best swimmers in nature: sperm cells.
Bind Therapeutics, currently developing a nanotech delivery platform for cancer, raised $70.5 million in a public offering of 4,700,00 shares at $15 each. The company began trading Friday under the ticker symbol "BIND."